Greenwich LifeSciences has shared important updates on the phase 3 Flamingo-01 trial, which is researching GLSI-100, a new immunotherapy for patients with a specific...
Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy.
This effort, officially...
Kintara Therapeutics has started a clinical trial to study REM-001, targeting patients with cutaneous metastatic breast cancer (CMBC).
This trial, which is open to...